Thursday, February 1, 2018

Gottlieb Lays Out Risk-Based Approach For Compounding GMPs ...

Inside Health Policy-3 hours ago
FDA Commissioner Scott Gottlieb told legislators Tuesday (Jan. 30) that FDA will take a risk-based approach to both the yet-to-be-finalized 503B-lite category of compounders and the new model agreement between states and FDA on oversight of compounders that ship products out of state. Gottlieb emphasized that FDA ...
Post a Comment